Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643

Citation
Ml. Rose et al., Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643, CARCINOGENE, 20(11), 1999, pp. 2075-2081
Citations number
34
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CARCINOGENESIS
ISSN journal
01433334 → ACNP
Volume
20
Issue
11
Year of publication
1999
Pages
2075 - 2081
Database
ISI
SICI code
0143-3334(199911)20:11<2075:DGPTDO>2.0.ZU;2-O
Abstract
Previous studies demonstrated that dietary glycine prevents elevated rates of cell proliferation following treatment with the peroxisome proliferator and liver carcinogen WY-14,643, Since increased cell replication is associa ted with the development of hepatic cancer caused by peroxisome proliferato rs, glycine may have anti-cancer properties. Therefore, experiments were de signed to test the hypothesis that dietary glycine would inhibit the hepato carcinogenic effect of WY-14,643, Male F344 rats were fed four different NI H 07-based diets: 5% glycine; 5% valine for nitrogen balance (control); 0.1 % WY-14,643 + 5% valine (WY14,643); 0.1% WY-14,643 + 5% glycine (WY-14,643 + glycine), Food consumption did not differ among the groups, but WY-14,643 -fed rats weighed 10-25% less than expected based on previous studies. Seru m glycine levels were elevated 4-5-fold by glycine-containing diets; howeve r, the 10-fold increase in peroxisomal enzyme activity caused by WY-14,643 was unaffected by the addition of 5% glycine to the diet. After 22 weeks, l ivers from rats fed WY-14,643 had a similar incidence and multiplicity of p roliferative lesions (foci and adenomas) to those fed WY-14,643 + glycine, Moreover, cell proliferation in the surrounding 'normal' parenchyma (labeli ng index approximate to 4%) and foci (labeling index approximate to 50%) di d not differ between WY-14,643 and WY-14,643 + glycine-fed rats. However, a fter 51 weeks of dietary exposure to WY-14,643, glycine prevented formation of small (0-5 mm diameter) tumors by 23 % and inhibited the development of medium size (5-10 mm) tumors by 64%, Furthermore, glycine prevented the fo rmation of the largest tumors (>10 mm) by nearly 80%, Thus, glycine did not inhibit early foci formation; however, it significantly decreased their ab ility to progress to tumors. Moreover, the inhibitory effect of glycine was greater with increasing tumor size, These studies demonstrate that dietary glycine prevents the development of hepatic tumors caused by the peroxisom e proliferator WY-14,643 consistent with the idea that it may be an effecti ve chemopreventive agent.